Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

Cancer Management and Research

Volumn 5, Issue 1, 2013, Pages 205-214

  Merlini, Laura ^a   Cartenì, Giacomo ^b   Iacobelli, Stefano ^c   Stelitano, Caterina ^d   Airoldi, Mario ^e   Balcke, Peter ^f   Keil, Felix ^g   Haslbauer, Ferdinand ^e   Belton, Laura ^h   Pujol, Beatriz ⁱ  

^a Ospedale Civile Di Vicenza   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c Ospedale Clinicizzato SS Annunziata   (Italy)

^d BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^e Azienda Ospedaliero Universitaria Le Molinette ^*  (Australia)

^f Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^g Hanusch Krankenhaus der Wiener Gebietskrankenkasse   (Australia)

^h AMGEN LTD   (United Kingdom)

ⁱ AMGEN INC   (United States)

Author keywords

Erythropoiesis stimulating agent; Hemoglobin; Iron; Management; Transfusion

Indexed keywords

HEMOGLOBIN; IRON;

ADULT; ANEMIA; ARTICLE; AUSTRALIA; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PATIENT; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IRON THERAPY; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN ATTITUDE; PREVALENCE; SOLID TUMOR;

EID: 84883254162     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: 10.2147/CMAR.S45236     Document Type: Article

References (15)

1. Ludwig H, Van Belle S, Barrett-Lee P, etal. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-2306.
2. Aapro MS, Cameron DA, Pettengell R, etal. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer. 2006;42(15): 2433-2453.
3. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214-2221.
4. Harper P, Littlewood T. Anaemia of cancer: impact on patient fatigue and long-term outcome. Oncology. 2005;69 Suppl 2:2-7.
5. Calabrich A, Katz A. Management of anemia in cancer patients. Future Oncol. 2011;7(4):507-517.
6. Aapro MS, Link H. Sep 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist. 2008;13 Suppl 3:33-36.
7. Schrijvers D, De Samblanx H, Roila F; for ESMO Guidelines Working Group. Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol. 2010;21 Suppl 5:v244-v247.
8. Aapro M, Österborg A, Gascón P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol. 2012;23(8):1954-1962.
9. Schrijvers D. Management of anemia in cancer patients: transfusions. Oncologist. 2011;16 Suppl 3:12-18.
10. Amgen Europe BV. Aranesp® Annex I Summary of Product Characteristics. The Netherlands: Amgen Europe BV; 2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Info rmation/human/000332/WC500026149.pdf. Accessed June 27, 2013.
11. Rizzo JD, Somerfield MR, Hagerty KL, etal. Use of epoetin and darbepoetin in patients with cancer: 2007American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008;26(1):132-149.
12. Castaigne S, Tourani JM, Delaloge S, Hennequin C, Zureik M, Lemarié E. High prevalence of anaemia among French hospitalized cancer patients: A one-day cross-sectional survey. Haematologica. 2007;92 Suppl 2:28. Abstract 0077.
13. Schmitz S, Chatsiproios D, Sandermann A, Link H. High prevalence of anemia among cancer patients in outpatient clinics in Germany: A two-day cross-sectional survey. Onkologie. 2008;31 Suppl 4:220. Abstract.
14. Verbeke N, Beguin Y, Wildiers H, etal. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). Support Care Cancer. 2012;20(1):23-28.
15. Steegmann JL, Sánchez Torres JM, Colomer R, etal. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey. Clin Transl Oncol. 2013;15(6):477-483.